Skip to content
SpringWorks Therapeutics logo — company profile

SpringWorks Therapeutics

Founded 2017 United States Stamford, United States 372 employees Post-IPO Equity Total: $1.02B Biopharma, Biotechnology +1

General Information

Company Name SpringWorks Therapeutics
Founded Year 2017
Location United States Stamford, United States
Founders / Decision Makers
Team member Team member
Employees 372
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with SpringWorks Therapeutics. To contact SpringWorks Therapeutics, visit springworkstx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SpringWorks Therapeutics compare?

A PDF of SpringWorks Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SpringWorks Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SpringWorks Therapeutics

SpringWorks Therapeutics is a commercial-stage biopharmaceutical company that utilizes a precision medicine approach to develop and deliver life-changing medicines for individuals grappling with severe rare diseases and cancer. Founded in 2017, the company boasts a diversified targeted oncology pipeline spanning solid tumors and hematological cancers. This pipeline includes clinical trials in rare tumor types and highly prevalent, genetically defined cancers. Headquartered in the United States, SpringWorks recently received a substantial $275.00 million in Post-IPO Equity investment on 05 December 2023, showing promising growth potential and attracting interest from investors.

Business keywords: biopharmaceutical, precision medicine, rare diseases, cancer, oncology, pipeline, clinical trials, targeted therapy, genetically defined cancers

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $275.00M -
05 Dec 2023
Post IPO Equity $225.00M 5
Boxer Capital, EcoR1 Capital +3
07 Sep 2022
Post IPO Equity $287.50M -
07 Oct 2020
Series B $125.00M 5
Bain Capital, HBM Healthcare Investments +3
01 Apr 2019
Series A $103.00M -
25 Sep 2017

SpringWorks Therapeutics Alternatives & Competitors

View All Alternatives
SpringWorks Therapeutics vs

Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically-...

Post-IPO Equity
69 employees
Biopharma, Biotechnology
SpringWorks Therapeutics vs

Overcoming Resistance In Cancer

Post-IPO Equity
119 employees
Biopharma, Biotechnology
SpringWorks Therapeutics vs
Tyra Biosciences
Tyra Biosciences United States

TYRA is focused on developing next-generation precision medicines that target large opportunities in...

85 employees
Biotechnology, Health and Wellness

FAQ About SpringWorks Therapeutics

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors an...
SpringWorks Therapeutics was founded in 2017.
SpringWorks Therapeutics is headquartered in Stamford, United States.
SpringWorks Therapeutics operates in Biopharma, Biotechnology and Health and Wellness. Its work centres on biopharmaceutical, precision medicine, rare diseases and cancer.
SpringWorks Therapeutics has approximately 372 employees.
SpringWorks Therapeutics has completed 5 funding rounds, raising a total of $1.02B. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to SpringWorks Therapeutics include Aadi Bioscience, Inc, ORIC Pharmaceuticals Inc., Tyra Biosciences, OncXerna Therapeutics , Sierra Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SpringWorks Therapeutics and Aadi Bioscience, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SpringWorks Therapeutics, https://bouncewatch.com/company/springworks-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout